Zhongchao Inc. (ZCMD)
NASDAQ: ZCMD · Real-Time Price · USD
0.7200
+0.0122 (1.72%)
At close: Nov 6, 2025, 4:00 PM EST
0.6660
-0.0540 (-7.50%)
After-hours: Nov 6, 2025, 4:33 PM EST
Zhongchao Revenue
Zhongchao had revenue of $5.60M in the half year ending June 30, 2025, a decrease of -46.02%. This brings the company's revenue in the last twelve months to $13.12M, down -24.64% year-over-year. In the year 2024, Zhongchao had annual revenue of $15.86M, down -18.37%.
Revenue (ttm)
$13.12M
Revenue Growth
-24.64%
P/S Ratio
0.89
Revenue / Employee
$118,176
Employees
111
Market Cap
16.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.86M | -3.57M | -18.37% |
| Dec 31, 2023 | 19.43M | 5.28M | 37.33% |
| Dec 31, 2022 | 14.15M | -2.15M | -13.16% |
| Dec 31, 2021 | 16.30M | -1.69M | -9.41% |
| Dec 31, 2020 | 17.99M | 3.11M | 20.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ZCMD News
- 1 year ago - Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications - PRNewsWire
- 1 year ago - Zhongchao Inc. Announces 1-for-10 Share Consolidation - PRNewsWire
- 2 years ago - Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments - PRNewsWire
- 2 years ago - Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day - PRNewsWire
- 2 years ago - Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients - PRNewsWire
- 2 years ago - Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management - PRNewsWire
- 2 years ago - Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education - PRNewsWire
- 2 years ago - Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment - PRNewsWire